
ABPI Patient Advisory Council
Council members provide the Association’s Board and its senior team with meaningful insights into the patient experience, to inform strategy, policy priorities and work.
ABPI Patient Advisory CouncilNHS-Industry Partnership Case Studies Repository
Explore examples of how collaboration and partnership can support delivery of NHS priorities and enable the ‘triple win’ - of improved patient outcomes, more efficient use of NHS resources and evidence of impact for industry – as well as replication and scaling across the NHS.
NHS-Industry Partnership Case Studies Repository
NHS engagement

New guidance to help the NHS and the pharmaceutical industry work successfully together.

The UK Life Sciences Industrial Strategy should be required reading for every healthcare leader in the UK. It makes clear that the NHS must be an active participant with industry in delivering the shared objective of outstanding patient outcomes.

This guidance has been developed by the AHSN Network and the ABPI.

The NHS Confederation's flagship conference bringing together the health and care sector between 15 to 17 June 2021
Place based partnerships
Working with patient organisations
Our ambition is to put patients at the heart of what we do, developing and delivering medicines which can have the most impact on people’s health and wellbeing. ABPI is committed to embedding system-wide patient and public involvement across the life sciences research sector.
Our work with patient organisations
Patient & public involvement

Our strategy sets out how the ABPI will deliver our commitments and make sure that patient engagement is consistently at the heart of our work.

In response to COVID-19, we thought it would be helpful to summarise some practical guidance from the Sourcebook, with the aim of supporting companies to work compliantly with patients and patient organisations.

The ABPI has produced this sourcebook to support pharmaceutical companies in working successfully and collaboratively with patients and patient organisations. We want to support relationships that are in the interests of patients and within the law and the ABPI Code. We also hope that the sourcebook will be helpful to patient organisations as they build partnerships with industry.

Involving the public and patients as equal partners in the discovery and development of medicines is vital. The ABPI works with patient organisations and our members to improve how this is done.
Academic collaboration

A quarter of a million people are employed in the UK’s life science sector today. We need a continuous supply of specialists to stay competitive, meet the demands of an evolving, technology-based world and pioneer the next wave of medicines and vaccines.

The UK is recognised worldwide as a leader in medical research and innovation, and the foundations for collaborations between industry and academia in the UK are exceptionally strong.